Cargando…
Enrichment of mutations in chromatin regulators in people with Rett Syndrome lacking mutations in MECP2
PURPOSE: Rett Syndrome (RTT) is a neurodevelopmental disorder caused primarily by de novo mutations (DNMs) in MECP2 and sometimes in CDKL5 and FOXG1. However, some RTT cases lack mutations in these genes. METHODS: Twenty-two RTT cases without apparent MECP2, CDKL5, and FOXG1 mutations were subjected...
Autores principales: | Sajan, Samin A., Jhangiani, Shalini N., Muzny, Donna M., Gibbs, Richard A., Lupski, James R., Glaze, Daniel G., Kaufmann, Walter E., Skinner, Steven A., Anese, Fran, Friez, Michael J., Jane, Lane, Percy, Alan K., Neul, Jeffrey L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107176/ https://www.ncbi.nlm.nih.gov/pubmed/27171548 http://dx.doi.org/10.1038/gim.2016.42 |
Ejemplares similares
-
When Rett syndrome is due to genes other than MECP2
por: Percy, Alan K., et al.
Publicado: (2018) -
Metabolic Signatures Differentiate Rett Syndrome From Unaffected Siblings
por: Neul, Jeffrey L., et al.
Publicado: (2020) -
Loss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome
por: Ward, Christopher S., et al.
Publicado: (2016) -
The relationship of Rett syndrome and MECP2 disorders to autism
por: Neul, Jeffrey Lorenz
Publicado: (2012) -
Rett Syndrome and MECP2 Duplication Syndrome: Disorders of MeCP2 Dosage
por: Collins, Bridget E, et al.
Publicado: (2022)